GlaxoSmithKline is expected to report a 2.4 billion third quarter profit. Pandemrix and Relenza will likely give this company some sick numbers for Q4.
http://www.cnbc.com/id/33481565
http://www.medicalvoices.org/en/vacc...on-a-year.html#
Last edited by macker; 10-26-2009 at 12:17 PM.
|